Scinai Immunotherapeutics reported cash from operations of -$2.46M and free cash flow of -$2.35M for the quarter ended Jun 2026, down 136.7% year over year. This cash flow statement covers 40 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2015 | Jun2015 | Dec2015 | Mar2016 | Dec2016 | Mar2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||||||||||
| Net Income | -11.99M | -9.05M | 37.43M | -1.50M | 1.95M | 14.37M | 6.48M | -3.52M | 10.79M | -11.45M | 10.67M | -2.16M | 6.64M | 10.46M | -2.26M | -1.57M | -2.19M | -2.47M | -2.15M | |||||||||||||||||||||
| Share-based CompensationStock Comp. | 2.58M | 2.53M | 0.73M | 0.48M | 0.41M | 0.31M | 0.40M | 0.25M | 0.21M | 0.23M | 0.45M | 0.19M | 0.65M | 0.14M | 0.20M | 0.00M | 0.32M | 0.07M | 0.23M | |||||||||||||||||||||
| Gains from Investment SecuritiesGains Investment | -2.57M | -0.77M | -0.59M | -0.22M | -0.10M | 0.00M | ||||||||||||||||||||||||||||||||||
| Non-cash ItemsNon-Cash Items | 1.09M | |||||||||||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -7.91M | -6.19M | -1.86M | -1.10M | -3.67M | -1.90M | -0.59M | -3.06M | -2.88M | -2.22M | -1.23M | -1.46M | -1.76M | -2.04M | -1.08M | -1.04M | -1.53M | -1.46M | -2.46M | |||||||||||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.16M | -0.02M | 0.00M | 0.00M | 0.06M | 0.07M | 0.11M | 0.06M | 0.04M | 0.07M | -0.04M | 0.11M | 0.01M | |||||||||||||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | ||||||||||||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.60M | 0.61M | -1.35M | 0.13M | 0.14M | 0.10M | 0.18M | 0.14M | 0.15M | 0.14M | 0.08M | 0.16M | 0.50M | 0.50M | 0.50M | 0.35M | 0.35M | 0.45M | 0.59M | |||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | -2.19M | 1.22M | 0.14M | 0.14M | -0.13M | -0.09M | -0.21M | 0.15M | -0.04M | -0.00M | 0.12M | 0.05M | -0.07M | -0.02M | -0.21M | |||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 0.55M | -0.61M | 0.77M | 0.31M | -0.75M | -0.14M | 0.89M | 0.63M | -0.66M | -0.10M | -0.21M | 0.31M | -0.18M | -0.23M | 0.26M | 0.17M | 0.11M | 0.20M | 0.07M | |||||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | -0.11M | -0.00M | -0.18M | 0.52M | -0.04M | -1.05M | -0.27M | -0.01M | -0.38M | -0.02M | -0.23M | -0.00M | -0.01M | -0.00M | -0.01M | -0.00M | -0.00M | -0.11M | ||||||||||||||||||||||
| Acquisitions | 2.75M | |||||||||||||||||||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.11M | -0.01M | -0.11M | -0.52M | 0.04M | -0.08M | -0.27M | -0.01M | -0.38M | -0.02M | -0.23M | -0.00M | -0.01M | -0.00M | -0.01M | -0.00M | 2.75M | -0.11M | ||||||||||||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 5.71M | 0.13M | -0.00M | -0.00M | 0.82M | 1.42M | 0.01M | 0.01M | ||||||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | -0.32M | -0.99M | 8.88M | 1.42M | 0.01M | 0.01M | 2.00M | |||||||||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 28.89M | 28.92M | 97.55M | 413.20M | ||||||||||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 29.49M | -0.68M | -20.02M | |||||||||||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.36M | 1.98M | -0.29M | -0.36M | -0.48M | -0.99M | -0.15M | -0.22M | -0.04M | 0.01M | -0.01M | -0.13M | 0.00M | |||||||||||||||||||||||||||
| Change in Cash | -8.69M | -5.21M | 6.62M | -1.99M | -4.11M | -2.97M | 5.76M | -3.29M | -3.29M | -1.15M | -1.47M | -0.04M | -1.87M | -1.92M | 0.93M | |||||||||||||||||||||||||
| Free Cash FlowFCF | -7.80M | -6.18M | -1.68M | -1.63M | -3.63M | -0.85M | -0.32M | -3.05M | -2.50M | -2.20M | -0.99M | -1.46M | -1.75M | -2.03M | -1.08M | -1.03M | -1.53M | -1.45M | -2.35M | |||||||||||||||||||||
| Net Cash FlowNCF | -8.33M | -7.19M | 6.91M | -1.63M | -3.63M | -1.98M | -0.86M | -3.06M | -3.25M | -2.24M | -1.46M | -0.04M | -1.75M | -2.03M | 0.92M | -1.05M | -1.54M | 1.29M | -2.58M |